Nantahala Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Nantahala Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Hold	648,885	–	–	0.07%	136
2025 Q4	$3.22M	Hold	648,885	–	–	0.11%	117
2025 Q3	$2.04M	Sell	648,885 -250,000	-28%	-$686K	0.07%	132
2025 Q2	$2.03M	Hold	898,885	–	–	0.08%	125
2025 Q1	$2.4M	Buy	898,885 +244,885	+37%	+$762K	0.1%	109
2024 Q4	$2.3M	Hold	654,000	–	–	0.1%	105
2024 Q3	$3.1M	Hold	654,000	–	–	0.16%	90
2024 Q2	$3.07M	Hold	654,000	–	–	0.18%	81
2024 Q1	$2.97M	Buy	+654,000	New	+$2.9M	0.17%	82

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nantahala Capital Management's ACHV Position: Q1 2026 in Review

Nantahala Capital Management held its Achieve Life Sciences (ACHV) position steady in Q1 2026 at 648,885 shares worth $1.91M. The position accounts for 0.07% of the portfolio, ranked #136.

Nantahala Capital Management first reported a position in ACHV in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.22M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Nantahala Capital Management held 648,885 shares of Achieve Life Sciences worth $1.91M as of Q1 2026.
Nantahala Capital Management left its Achieve Life Sciences share count unchanged in Q1 2026.
Achieve Life Sciences made up 0.07% of Nantahala Capital Management's portfolio in Q1 2026, its #136 holding.
Nantahala Capital Management first reported a position in Achieve Life Sciences in Q1 2024 and has held it in 9 quarters since.
Nantahala Capital Management's Achieve Life Sciences position peaked at $3.22M in Q4 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.